StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$39.84+1.96 (+5.17%)

Close on Oct 19, 2026Market cap $4.86BP/E 11.2Yield –

Supernus free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Supernus's free cash flow for the twelve months ending Sep 30, 2026 was $31.00M, down 73.9% year over year. For fiscal 2025 it was -$93.00M, down 1428.6% from the year before. The highest annual figure on record is $349.00M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$93.00M-1428.6%
FY2024Dec 31, 2024$7.00M–
FY2023Dec 31, 2023-$308.00M–
FY2022Dec 31, 2022-$9.00M-102.6%
FY2021Dec 31, 2021$349.00M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$83.00M–
Q2 FY2026Jun 30, 2026$222.00M+57.4%
Q1 FY2026Mar 31, 2026-$29.00M-141.4%
Q4 FY2025Dec 31, 2025-$245.00M–
Q3 FY2025Sep 30, 2025-$59.00M–
Q2 FY2025Jun 30, 2025$141.00M+67.9%
Q1 FY2025Mar 31, 2025$70.00M–
Q4 FY2024Dec 31, 2024-$33.00M–
Q3 FY2024Sep 30, 2024-$5.00M–
Q2 FY2024Jun 30, 2024$84.00M–
Q1 FY2024Mar 31, 2024-$39.00M–

More Supernus figures

See a number that looks wrong?